Around, a distributed next-generation video collaboration service, raised $10M in Series A funding.
Carvolution, a Bannwil, Canton Bern, Switzerland-based car subscription company, raised CHF15M in Series C funding.
RAW Labs, a Lausanne, Switzerland-based data management solution provider, completed a USD 5.5M pre-A funding round.
Novaremed AG, a Basel, Switzerland-based clinical-stage biopharmaceutical company, announced, signed an agreement with GEM Global Yield LLC SCS (GEM), a Luxembourg-based private, alternative investment group for a US $50m capital commitment.
Microcaps AG, a Zurich, Switzerland-based developer of formulation, processes and equipment to generate precision microcapsules, closed a CHF 5m seed financing.
Dating Group, a Malta-based global holding company in the dating and social discovery markets, acquired Once, a Pfäffikon SZ, Switzerland-based provider of an app for quality dating in Western Europe.
Angelini Pharma, a Rome, Italy-based international pharmaceutical company which is a part of the private Italian Angelini Group, acquired Arvelle Therapeutics, a Swiss-based biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders.
Garmin International and Garmin Services, units of Garmin Ltd. (NASDAQ: GRMN), acquired all the assets of Montgomery, Texas-based Geos Worldwide Limited and its subsidiaries.
QuantalRF, a Zürich, Switzerland-based RF semiconductor company developing transformative wireless communication solutions, closed a CHF17m (approx. $19m) Series B funding round.
Noema Pharma AG, a Basel, Switzerland-based clinical-stage company targeting orphan neurological disorders, raised a Series A financing round, raising CHF54m ($59m USD).
Pan European private equity firm Highland Europe closed its fourth fund, at €700M.
GUURU Solutions Ltd, a Zurich, Switzerland-based SaaS customer service startup, raised $5M in a Series A extension funding.
Pharvaris, a Zug, Switzerland-based clinical-stage company, closed an $80m Series C financing bringing its total venture funding to over $160m to date.
Kandou, a Lausanne, Switzerland-based fabless semiconductor company, raised $92.3M in Series C funding.
Synendos Therapeutics, a Basel, Switzerland-based biopharmaceutical company developing a new class of small molecules aimed at restoring the natural functioning of the endocannabinoid system in the brain with the potential for treating a wide range of Central Nervous System (CNS) disorders, raised CHF20m in Series A financing.